Trials / Terminated
TerminatedNCT01398839
Safety Study of the VEGA UV-A System to Treat Ectasia
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- Topcon Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL) when used to treat ectasia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VEGA UV-A Illumination System | Only subjects assigned to the treatment group will receive treatment with the UV Light |
| DRUG | Riboflavin | Both treatment and sham groups will receive riboflavin |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-07-21
- Last updated
- 2022-06-29
- Results posted
- 2013-03-04
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01398839. Inclusion in this directory is not an endorsement.